BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25240929)

  • 1. The cytoskeletal inhibitors latrunculin A and blebbistatin exert antitumorigenic properties in human hepatocellular carcinoma cells by interfering with intracellular HuR trafficking.
    Doller A; Badawi A; Schmid T; Brauss T; Pleli T; zu Heringdorf DM; Piiper A; Pfeilschifter J; Eberhardt W
    Exp Cell Res; 2015 Jan; 330(1):66-80. PubMed ID: 25240929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HuR translocation to the cytoplasm of cancer cells in actin-independent manner.
    Habiba U; Kuroshima T; Yanagawa-Matsuda A; Kitamura T; Chowdhury A; Jehung JP; Hossain E; Sano H; Kitagawa Y; Shindoh M; Higashino F
    Exp Cell Res; 2018 Aug; 369(2):218-225. PubMed ID: 29807023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-dependent association with myosin IIA promotes F-actin-guided trafficking of the ELAV-like protein HuR to polysomes.
    Doller A; Schulz S; Pfeilschifter J; Eberhardt W
    Nucleic Acids Res; 2013 Oct; 41(19):9152-67. PubMed ID: 23921630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-constitutive HuR phosphorylation at Ser 318 by PKC{delta} propagates tumor relevant functions in colon carcinoma cells.
    Doller A; Winkler C; Azrilian I; Schulz S; Hartmann S; Pfeilschifter J; Eberhardt W
    Carcinogenesis; 2011 May; 32(5):676-85. PubMed ID: 21310943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of clathrin-mediated endocytosis via cytoskeletal change by epithelial to fibroblastoid conversion in HepG2 cells: a possible mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
    Murata K; Sakamoto A
    Int J Oncol; 2008 Dec; 33(6):1149-55. PubMed ID: 19020747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of intracellular trafficking and secretion of adiponectin by myosin II.
    Bedi D; Dennis JC; Morrison EE; Braden TD; Judd RL
    Biochem Biophys Res Commun; 2017 Aug; 490(2):202-208. PubMed ID: 28606474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer.
    Zhu H; Berkova Z; Mathur R; Sehgal L; Khashab T; Tao RH; Ao X; Feng L; Sabichi AL; Blechacz B; Rashid A; Samaniego F
    Mol Cancer Res; 2015 May; 13(5):809-18. PubMed ID: 25678597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HuR knockdown changes the oncogenic potential of oral cancer cells.
    Kakuguchi W; Kitamura T; Kuroshima T; Ishikawa M; Kitagawa Y; Totsuka Y; Shindoh M; Higashino F
    Mol Cancer Res; 2010 Apr; 8(4):520-8. PubMed ID: 20332213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen regulates the level and subcellular distribution of the AU-rich ribonucleic acid-binding protein HuR both in vitro and in vivo.
    Sheflin LG; Zhang W; Spaulding SW
    Endocrinology; 2001 Jun; 142(6):2361-8. PubMed ID: 11356683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes.
    Zhang M; Rao PV
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4130-8. PubMed ID: 16249490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells.
    Guo X; Hartley RS
    Cancer Res; 2006 Aug; 66(16):7948-56. PubMed ID: 16912169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells.
    Nagahara T; Okano J; Murawaki Y
    Oncol Rep; 2007 Nov; 18(5):1281-90. PubMed ID: 17914586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2.
    Young LE; Moore AE; Sokol L; Meisner-Kober N; Dixon DA
    Mol Cancer Res; 2012 Jan; 10(1):167-80. PubMed ID: 22049153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of E2F1-cyclin E1-E2 circuit down regulation in hepatocellular carcinoma cells.
    Farra R; Dapas B; Pozzato G; Scaggiante B; Agostini F; Zennaro C; Grassi M; Rosso N; Giansante C; Fiotti N; Grassi G
    Dig Liver Dis; 2011 Dec; 43(12):1006-14. PubMed ID: 21831731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of CARM1 is linked to reduced HuR function in replicative senescence.
    Pang L; Tian H; Chang N; Yi J; Xue L; Jiang B; Gorospe M; Zhang X; Wang W
    BMC Mol Biol; 2013 Jul; 14():15. PubMed ID: 23837869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
    Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
    Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the ELAV-like protein HuR in human prostate carcinoma is an indicator of disease relapse and linked to COX-2 expression.
    Niesporek S; Kristiansen G; Thoma A; Weichert W; Noske A; Buckendahl AC; Jung K; Stephan C; Dietel M; Denkert C
    Int J Oncol; 2008 Feb; 32(2):341-7. PubMed ID: 18202756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-Phycocyanin inhibits MDR1 through reactive oxygen species and cyclooxygenase-2 mediated pathways in human hepatocellular carcinoma cell line.
    Nishanth RP; Ramakrishna BS; Jyotsna RG; Roy KR; Reddy GV; Reddy PK; Reddanna P
    Eur J Pharmacol; 2010 Dec; 649(1-3):74-83. PubMed ID: 20858479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mRNA stability alterations mediated by HuR are necessary to sustain the fast growth of glioma cells.
    Bolognani F; Gallani AI; Sokol L; Baskin DS; Meisner-Kober N
    J Neurooncol; 2012 Feb; 106(3):531-42. PubMed ID: 21935689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cytoskeleton inhibitors on deadhesion kinetics of HepG2 cells on biomimetic surface.
    Feng Z; Chen B; Tang SC; Liao K; Chen WN; Chan V
    Colloids Surf B Biointerfaces; 2010 Jan; 75(1):67-74. PubMed ID: 19720507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.